Brian E. Libby

454 total citations
4 papers, 77 citations indexed

About

Brian E. Libby is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Brian E. Libby has authored 4 papers receiving a total of 77 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Cellular and Molecular Neuroscience and 1 paper in Organic Chemistry. Recurrent topics in Brian E. Libby's work include Pharmacological Receptor Mechanisms and Effects (2 papers), Ion channel regulation and function (2 papers) and Neuroscience and Neuropharmacology Research (2 papers). Brian E. Libby is often cited by papers focused on Pharmacological Receptor Mechanisms and Effects (2 papers), Ion channel regulation and function (2 papers) and Neuroscience and Neuropharmacology Research (2 papers). Brian E. Libby collaborates with scholars based in United States. Brian E. Libby's co-authors include Nigel J. Liverton, Christopher F. Claiborne, Joseph J. Lynch, Kenneth S. Koblan, John A. McCauley, Bohumil Bednář, Rodney A. Bednar, Stanley L. Gaul, Kevin T. Nguyen and Scott D. Mosser and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Brian E. Libby

4 papers receiving 75 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian E. Libby United States 4 44 33 24 8 8 4 77
Giorgio Bonanomi Italy 6 61 1.4× 63 1.9× 33 1.4× 3 0.4× 4 0.5× 9 115
Victoria J. Barrett United Kingdom 9 30 0.7× 80 2.4× 36 1.5× 6 0.8× 3 0.4× 11 304
Michael F. Parker United States 6 28 0.6× 35 1.1× 16 0.7× 3 0.4× 6 0.8× 12 94
L. G. Payne United States 4 25 0.6× 48 1.5× 16 0.7× 4 0.5× 3 0.4× 5 80
Erik LaChapelle United States 6 53 1.2× 48 1.5× 25 1.0× 12 1.5× 9 116
Anna Aparicio United States 7 59 1.3× 42 1.3× 15 0.6× 4 0.5× 8 94
Peter Dove United States 8 60 1.4× 35 1.1× 13 0.5× 11 1.4× 21 2.6× 14 150
Gerard M. Koether United States 5 63 1.4× 58 1.8× 29 1.2× 1 0.1× 7 0.9× 5 99
Konstantin Falahati Germany 6 40 0.9× 23 0.7× 15 0.6× 7 0.9× 7 102
Chris Walpole Canada 5 24 0.5× 53 1.6× 44 1.8× 1 0.1× 6 0.8× 5 100

Countries citing papers authored by Brian E. Libby

Since Specialization
Citations

This map shows the geographic impact of Brian E. Libby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian E. Libby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian E. Libby more than expected).

Fields of papers citing papers by Brian E. Libby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian E. Libby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian E. Libby. The network helps show where Brian E. Libby may publish in the future.

Co-authorship network of co-authors of Brian E. Libby

This figure shows the co-authorship network connecting the top 25 collaborators of Brian E. Libby. A scholar is included among the top collaborators of Brian E. Libby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian E. Libby. Brian E. Libby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
Beshore, Douglas C., Nigel J. Liverton, Charles McIntyre, et al.. (2010). Discovery of triarylethanolamine inhibitors of the Kv1.5 potassium channel. Bioorganic & Medicinal Chemistry Letters. 20(8). 2493–2496. 12 indexed citations
2.
Nguyen, Kevin T., Christopher F. Claiborne, John A. McCauley, et al.. (2007). Cyclic benzamidines as orally efficacious NR2B-selective NMDA receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 17(14). 3997–4000. 19 indexed citations
3.
Liverton, Nigel J., Rodney A. Bednar, Bohumil Bednář, et al.. (2007). Identification and Characterization of 4-Methylbenzyl 4-[(Pyrimidin-2-ylamino)methyl]piperidine-1-carboxylate, an Orally Bioavailable, Brain Penetrant NR2B SelectiveN-Methyl-d-Aspartate Receptor Antagonist. Journal of Medicinal Chemistry. 50(4). 807–819. 32 indexed citations
4.
Larsen, Scott D., et al.. (1996). Cyclopentene Synthesis from 1,3-Dienes via Base-Induced Ring Contraction of 3,6-Dihydro-2H-thiopyrans:  Studies on Diastereoselection and Mechanism. The Journal of Organic Chemistry. 61(14). 4725–4738. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026